Century Therapeutics, Inc. (52)

Browse by Contract Category

Contracts

Research Collaboration and License Agreement, by and between Century Therapeutics, Inc. and Bristol-Myers Squibb Company, dated January 7, 2022 (Filed With SEC on March 17, 2022)
Letter Agreement by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated January 7, 2022 (Filed With SEC on March 17, 2022)
Securities Purchase Agreement, by and between Century Therapeutics, Inc. and Bristol-Myers Squibb Company, dated January 7, 2022 (Filed With SEC on January 10, 2022)
License Agreement (Reprogramming), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018 (Filed With SEC on June 15, 2021)
2021 Equity Incentive Plan (Filed With SEC on June 14, 2021)
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 17, 2022)
License Agreement (Differentiation), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018 (Filed With SEC on June 15, 2021)
2021 Employee Stock Purchase Plan (Filed With SEC on June 14, 2021)
Form of Underwriting Agreement (Filed With SEC on June 14, 2021)
Specimen Common Stock Certificate of Registrant (Filed With SEC on June 14, 2021)
Executive Employment Agreement, by and between the Registrant and Luis Borges, Ph.D., datedMay 26, 2021 (Filed With SEC on June 14, 2021)
Executive Employment Agreement, by and between the Registrant and Adrienne Farid, Ph.D., dated May 26, 2021 (Filed With SEC on June 14, 2021)
Executive Employment Agreement, by and between the Registrant and Gregory Russotti, Ph.D., dated (Filed With SEC on June 14, 2021)
License Agreement, by and among the Governing Council of the University of Toronto, the McMaster University and Empirica Therapeutics, dated January 22, 2019 (Filed With SEC on May 28, 2021)
Offer Letter, by and between the Registrant and Alessandro Riva, M.D., dated May 19, 2021 (Filed With SEC on May 28, 2021)
Offer Letter, by and between the Registrant and Kimberly Blackwell, M.D., dated May 19, 2021 (Filed With SEC on May 28, 2021)
Offer Letter, by and between the Registrant and Cynthia Butitta, dated February 25, 2021 (Filed With SEC on May 28, 2021)
Offer Letter, by and between the Registrant and Joseph Jimenez, dated February 16, 2021 (Filed With SEC on May 28, 2021)
Executive Employment Agreement, by and between the Registrant and Gregory Russotti, Ph.D., dated (Filed With SEC on May 28, 2021)
Executive Employment Agreement, by and between the Registrant and Adrienne Farid, Ph.D., dated May 26, 2021 (Filed With SEC on May 28, 2021)
Executive Employment Agreement, by and between the Registrant and Luis Borges, Ph.D., datedMay 26, 2021 (Filed With SEC on May 28, 2021)
Executive Employment Agreement, by and between the Registrant and Hyam Levitsky, M.D., dated May 26, 2021 (Filed With SEC on May 28, 2021)
Executive Employment Agreement, by and between the Registrant and Michael Diem, M.D., dated May 26, 2021 (Filed With SEC on May 28, 2021)
Executive Employment Agreement, by and between the Registrant and Osvaldo Flores, Ph.D., dated May 26, 2021 (Filed With SEC on May 28, 2021)
License Agreement, by and between Inscripta, Inc. and Century Therapeutics, Inc., dated January 1, 2019 (Filed With SEC on May 28, 2021)
Investors Rights Agreement, by and among the Registrant and each of the investors listed on Schedule A thereto, dated February 25, 2021 (Filed With SEC on May 28, 2021)
Warrant to Purchase Units of Century Therapeutics, LLC, in favor of Hercules Technology Management Co II, Inc., dated September 14, 2020 (Filed With SEC on May 28, 2021)
Form of Stock Option Grant Notice and Award Agreement, under the 2021 Plan (Filed With SEC on May 28, 2021)
Form of Indemnification Agreement by and between the Registrant and its individual directors and officers (Filed With SEC on May 28, 2021)
2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
Amendment No. 1 to 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
Amendment No. 2 to 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
Amendment No. 3 to 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
Amendment No. 4 to 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
Amendment No. 5 to 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
Form of Restricted Stock Award Agreement, under the 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
Form of Non-Qualified Stock Option Agreement, under the 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
Form of Incentive Stock Option Agreement, under the 2018 Stock Option and Grant Plan (Filed With SEC on May 28, 2021)
Form of Restricted Stock Unit Grant Notice and Award Agreement, under the 2021 Plan (Filed With SEC on May 28, 2021)
Loan and Security Agreement, by and between Century Therapeutics, Inc. and Hercules Capital, Inc (Filed With SEC on May 28, 2021)
Amended and Restated Option Agreement, by and between Century Therapeutics, Inc. and Bayer HealthCare LLC, dated February 25, 2021 (Filed With SEC on May 28, 2021)
Master Collaboration Agreement, by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated October 21, 2019 (Filed With SEC on May 28, 2021)
Amendment No. 1 to Master Collaboration Agreement, by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated July 17, 2020 (Filed With SEC on May 28, 2021)
Amendment No. 2 to Master Collaboration Agreement by and between Century Therapeutics, Inc. and (Filed With SEC on May 28, 2021)
Amendment No. 3 to Master Collaboration Agreement by and between Century Therapeutics, Inc. and (Filed With SEC on May 28, 2021)
Letter Agreement, by and among Century Therapeutics, Inc., FUJIFILM Cellular Dynamics, Inc. and Wisconsin Alumni Research Foundation, dated July 2, 2019 (Filed With SEC on May 28, 2021)
License Agreement (Differentiation), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018 (Filed With SEC on May 28, 2021)
Amendment No. 1 to License Agreement (Differentiation), by and between Century Therapeutics, Inc (Filed With SEC on May 28, 2021)
License Agreement (Reprogramming), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated September 18, 2018 (Filed With SEC on May 28, 2021)
Amendment No. 1 to License Agreement (Reprogramming), by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated March 23, 2021 (Filed With SEC on May 28, 2021)
Manufacturing and Supply Agreement, by and between Century Therapeutics, Inc. and FUJIFILM Cellular Dynamics, Inc., dated March 23, 2021 (Filed With SEC on May 28, 2021)
Sublicense Agreement, by and between iCELL Inc. and Century Therapeutics, Inc., dated March 20, 2020 (Filed With SEC on May 28, 2021)